Hi everyone,
Finally got my results over the phone this afternoon. Things are trending in the right direction, but clearly it's still early in treatment:
Date Type FISH PCR Log Change Log Change
(Emory Std Baseline) (Baseline from dx ratio)
--------- ----- ---- ------- -------------------- ------------------------
3/30/11 BMB/A 98% 0.25 0.50 0.00
4/12/11 ----------------------- STARTED GLEEVEC 400MG -----------------------
7/15/11 Blood 5% 0.0153 -0.72 -1.21
10/12/11 Blood 0% 0.0016 -1.67 -2.19
I have a few questions about these results in anticipation of my appointment at the end of the week ... any feedback would really be helpful:
- FISH negative at 6 months (probably sooner), but no MMR at 6 months. Is this considered average, above average, or fast for Gleevec 400mg?
- Should they be looking for blast count in the peripheral blood sample? It wasn't mentioned to me over the phone, but I'm wondering if that's standard analysis, since it does appear that disease progression could occur even with good numbers. Yikes. Am I understanding that correctly?
- The PCR ratio was reported as 1.53E-02 at 3 months, and 1.60E-03 at 6 months, so the sensitivity is 4 places to the right of the decimal point. Is that pretty standard, or are there more sensitive measures out there?
- I'm trying to decide which log change is most appropriate for me to track. Emory Winship has a pre-defined baseline that comes from an average PCR ratio at diagnosis for chronic phase patients. I am also tracking the log change from my PCR ratio at diagnosis, which is more favorable. I don't think that Emory uses International Scale.
Thanks y'all!